Pharmacological studies of the therapy of shock.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001804:Blood Transfusion, Autologous; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D005021:Ethylamines / Q000627:therapeutic use; D000882:Haplorhini; D006339:Heart Rate / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D008251:Macaca; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D012756:Sheep; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D005021:Ethylamines; D009946:Organothiophosphorus Compounds; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D010100:Oxygen